These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8566022)

  • 1. Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments.
    Vidović D; Falcioni F; Siklodi B; Belunis CJ; Bolin DR; Ito K; Nagy ZA
    Eur J Immunol; 1995 Dec; 25(12):3349-55. PubMed ID: 8566022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of class II major histocompatibility complex molecules on antigen presenting cells after interaction with helper T cells.
    Vidović D; Falcioni F; Bolin DR; Nagy ZA
    Eur J Immunol; 1995 May; 25(5):1326-31. PubMed ID: 7774635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
    Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
    Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation with superantigens induces programmed death in antigen-primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism.
    Damle NK; Leytze G; Klussman K; Ledbetter JA
    Eur J Immunol; 1993 Jul; 23(7):1513-22. PubMed ID: 8100773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antigen-presenting cell requirements of hapten-specific T cell lines restricted to class II determinants.
    Hanke JH; Cook RG; Lopez LA; Rich RR
    J Immunol; 1987 Apr; 138(8):2384-91. PubMed ID: 3494064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparate functions of I-A and I-E molecules on B cells as evidenced by the inhibition with anti-I-A and anti-I-E antibodies of polyclonal B cell activation.
    Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
    Eur J Immunol; 1989 Dec; 19(12):2227-35. PubMed ID: 2558020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
    Robbins PA; Maino VC; Warner NL; Brodsky FM
    J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
    Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
    J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton.
    Rasmussen AM; Horejsí V; Levy FO; Blomhoff HK; Smeland EB; Beiske K; Michaelsen TE; Gaudernack G; Funderud S
    Eur J Immunol; 1997 Dec; 27(12):3206-13. PubMed ID: 9464807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.